Infectious disease Flashcards
chlamydia
doxycycline 100mg bid x 7 days or azithromycin 1 gm po x 1
Alternate: emycin 500mg po QID or
levofloxin 500mg daily x 7 days
gonorrhea
rocephin 250mg IM or cefixime 400mg po one dose
Alternate: cefpodoxime 400mg po x 1 or
azithromycin 2 gm po x 1
syphilis <1 year
benzathine PCN 2.4 MU IM one dose
Alternative: doxycycline 100mg BID x 14 days
syphilis > 1 year
benzathine PCN 2.4 MU IM weekly x 3 weeks
Alternate: doxycycline 100mg BID x 30 days
neurosyphilis
aqueous PCN G 3-4MU IV every 4 hours or 24 MU continuous IV x 10-14 days
alternate: ceftriaxone 2 gm IV daily x 10-14 days
PID *outpatient
rocephin 250mg IM x 1 plus doxycycline 100mg BID x 14days, +/- flagyl 500mg BID x 14 days
PID *inpatient
cefoxitin or cefotetan IV plus doxy 100mg BID po X 14 days
alternate: amp/sulb IV plus doxy as above
epididymitis
rocephin 250mg IM x 1 plus doxy 100mg BID x 10 days
alternative:ofloxacin 300mg po BID x 10days or
levofloxacin 500mg daily x 10 days
screening for chlamydia
best test: DNA/RNA test by PCR on urine
all sexually active female 1 sex partner
*inconsistent use of barrier contraception
*
chlamydia tx in pregnancy
azithromycin 1 gm po x 1
GC tx in pregnancy
rocephin and azith, if PCN allergy-azith 2gm po x 1
syphilis tx in pregnancy
benzathine PCN
**if PCN allergy-desensitize to PCN and tx with PCN!!
tx herpes in pregnancy
acyclovir for acute and suppressive therapy
*last month of pregnancy to prevent recur and need for c section
diagnostic criteria for PID
- lower abd pain
- cervical motion tenderness, adnexal tenderness
- absence of other diagnosis
- mucopurulent cervicitis
complications of PID
- infertility
- ectopic pregnancy
- perihepatitis
organisms involved in PID
- GC, chlamydia
- M,genitalium, M. hominis
- anaeobes
primary syphilis symptoms and diagnosis
symptoms: single painless,indurated lesion, painless inguinal adenopathy
Dx:dark field exam, VDRL is negative
secondary syphilis, symptoms
- rash, arthritis, hepatitis, nephrotic syndrome
* condylomata lats, aseptic meningitis, generalized lymphadenopathy
latent syphilis
positive serology but no clinical manifestations
tertiary syphilis
gummas
CV:aortitis, AR,aneuysm, coronary ostial stenosis
CNS:CVA, encephalitis;general paresis (20yr infection)-personality, affect, intellect, speech;Tabes dorsalis (25-30yr)-ataxia,wide base gait,paresthesia, areflexia,AR pupil, demyelination etc
syphilis serology
*RPR,VRDL:screening or quant. of serum antibody,follow titer after treatment
*treponemal tests: FTA-ABS
TPPA-used to confirm , remain positive after treatment
indications for lumbar puncture w suspect syphilis
- neuro s/s
- RPR or VRDL titer >1:32
- tx failure
- HIV+ w CD4 <350
CSF findings in syphilis
Increased:protein, lymphocytes
Positive:VDRL, FTA-ABS
negative FTA-ABS on CSF
rules out neurosyphilis
if VRDL is + and FTA-ABS is - then
false + VDRL
HSV 1&2 are
double stranded DNA virus that either can cause oral or genital infection
More common cause of herpes labialis
HSV1
more common cause of genital herpes
HSV2
HSV initial episode may have these S/S
- fever, headache, malaise, myalgia, pain
- dysuria, vaginal and urethral discharge
- tender inguinal lymphadenopathy
- aseptic meningitis
Diagnosis of HSV
viral culture or PCR
- type specific serology testing-only useful for diagnosing chronic
- PCR on CSF-best to dx herpes encephalitis
Tx first episode of HSV
acyclovir 400mg TID
famciclovir 250mg TID
valacyclovir 1 gm BID
* all for 7-10 days
Tx recurrent HSV
acyclovir 400mg TID X 3-5days
famciclovir 250mg TID X 7-10days
valacyclovir 1gm BID X 7-10days
suppression of HSV
acyclovir 400mg BID
famciclovir 125mg BID
valacyclovir 500mg daily
Tx severe HSV or herpes encephalitis
IV acyclovir
other herpes simples virus syndromes
- herpetic whitlow
- keratitis
- hepatitis
- Bells palsy
HPV-human papillomavirus
double stranded DNA
HPV types assoc with anogenital warts
6 & 11
HPV virus assoc with cervical cancer
16, 18, 31, 33, 45
HPV quadravalent vaccine is approved for males and females ages 9-26 are
6, 11, 16, 18
trichomoniasis
yellow, frothy discharge pH >or= 4.5 dysuria, strawberry cervix *Dx: wet mount or culture, OSOM rapid test *TX:flagyl or tinidazole 2gm single dose
bacterial vaginosis (gardnerella)
- thin whitish dischg,odor. pH>4.5, amine odor w KOH
- clue cells on wet mount(culture not needed), rapid tests
- tx:flagyl 500mg BID x 7days or vaginal clindamycin cream 2% nightly x 7 days
candidiasis
- thick curd dischg vaginal erythema,pruritis, dysuria,pH<4.5
- TX: fluconaxone 150mg x 1, miconazole 100mg vaginal tablet. or clotrimazole 100mg vaginal tablet once daily x 7 days
atrophic vaginitis
- watery, yellow discharge, dyspareunia, vagina thin and pale
- wet mount:numerous WBC, no bacteria, negative KOH
- tx; topical estrogen
HIV + class 1
asymptomatic HIV infection or low viral load <1500RNA copies
HIV+ class II
symptomatic HIV infection, AIDS, acute seroconversion or high viral load >1500 RNA copies
prophylaxis against HIV after percutaneous injury, LOW RISK exposure
- class 1: 2 drugs x 4 weeks
- class II: 3 drugs x 4 weeks
- unknown status: no tx or 2 drugs x 4 wks if risk factors for HIV
prophylaxis against HIV infection after percutaneous injury with HIGH RISK exposure
class 1 & class II & unknown status ALL:3 drugs X 4 weeks
HIV low risk exposure
injury caused by solid needles, superficial injuries
HIV high risk exposure
injury by large bore hollow needle, deep puncture, device visible contaminated with blood, needle used in a patient artery or vein
HIV 2 drug regimen for prophylaxis
- Ziduvadine-lamivudine
* tenofovir-emtricitabinne
HIV prophylaxis 3 drug regimen
- ritonavir-lopinavir
- ritonavir plus atazanavir
- ritonavir plus darunavir
risk of HIV transmission from sexual exposure
*receptive anal intercourse: 1-30%
*insertive anal or receptive vaginal: 0.1-10%
*insertive vaginal intercourse: 0.1-1%
Risk is lower with oral intercourse
Indications for Postexposure prophylaxis HIV:
- persons exposed to known HIV+ source patients
- persons exposed to select high risk population with unknown HIV status
- men who have sex w men or both men and women
- commercial sex workers, perpetrators of sexual assault
- IVDU, persons with hx of incarceration
- persons from country where sero+ of HIV is >/= 1%
- persons having sex with someone in one of these groups
greatest benefit of HIV prophylaxis medications
*when started within 36 hours after exposure
Evaluation of HIV+ patient
- PPD5mm=INH x 9 months)
- hepatitis A,B,C serology, toxoplasma & CMV serology
- Vaccines: Hep A&B,influenza, pneumococcal, H. inf type b
- PAP baseline, 6 mo then yearly if normal
- anal screen for HPV
- CD4 cell count,genotype for antiretroviral drug resist., G6PD
- RNA viral load
- lipid,CPK,amylase,lipase,CBC,LFT,CMP
- CXR
start antiretroviral tx in HIV+ when CD4 count
<500
start pneumocystis prophylaxis in HIV+ patient when CD4 count
<200
HIV+ patient with +toxoplasma antibody, start prophylaxis when CD4 count
<100
*Bactrum, or dapsone + pyrimethamine + leucovorin
HIV+ patient start prophylaxis for M. avium when CD4 count
<50
Best predictor of prognosis in HIV
HIV RNA viral load
Pregnancy and HIV infection
- all start on 3 drug tx regardless of CD4 count to prevent mother to fetal transmission
- Preferred regimen:Zidovudine + laivudine + lopinavir/retonavir
diseases seen in HIV+ patient with CD4 count >500
vulvovaginal candidiasis
diseases seen in HIV+ patient with CD4 counts 200-500
*hairy leukoplakia, oral candidiasis, recur HSV, varicella-zoster,seborrheic dermatitis, recur bacterial infections, TB, kaposi sarcoma, peripheral B cell non-hodgkins lymphoma
disease in HIV+ patient with CD4 counts 50-200
PCP
diseases seen in HIV+ patient with CD4 counts <50
- MAC, cryptococcosis, CMV, cryptosporidiosis
- histoplasmosis, toxoplasmosis, multifocal leukoencephalopathy
- CNS lymphoma
- dementia
Acute (HIV) retroviral syndrome
*s/s:skin rash, mouth ulcers,pharyngitis, gen. lymphadenopathy, oral candida
- mono like S/S 2-6wks after initial exposure
- dx confirmed: HIV RNA usually >50,000 copies or P24 antigen
- Rx: HAART x 6 months
early initiation of antiretroviral therapy reduces
- the sexual transmission of HIV
* the rate of disease progression
Indications for antiretroviral therapy
- CD4 <500, symptomatic HIV dz w any CD4 or HIV RNA
- acute retroviral syndrome (6 months)
- pt w hx of AIDS defining illness, HIV assoc nephropathy
- pregnant, active coinfection w Hep B or C
- after high risk exposure-4 weeks
most important test to follow after start of antiretroviral therapy for HIV
viral load
therapy for HIV
- 2 nuclosides + 1 protease inhibitor or 1 nonnucleoside
* 2 nuclosides + 2 protease inhibitors
recommended antiretroviral therapy
*efavirenz + (lamivudine or emtricitabine) + (zidovudine or tenofovir)
OR
*(lopinavir + ritonavir) + (lamivudine or emtricitabine) + zidovudine
indications for changing antiretroviral therapy :
*failure to achieve HIV viral load
- 3 fold or > increase from the nadir not attributed to intercurrent infections
- detection of viral isolate resistant to a drug
- drug toxicity, clinical progression of disease
in treating HIV patient, if see treatment failure
do viral resistance testing
IRIS-immune reconstitution inflammatory syndrome
- can see usually in pt with advanced HIV disease
- presents within 4 weeks of starting HAART
- present with odd presentations, inclluding infections
- see viral load decrease, CD4 decrease
* due to rapid expansion and dysregulation of antigen specific T cell response
indications for prophylaxis for pneumocystis
- CD4 <14
- prior PCP or persistent fever
- hx oropharyngeal candidiasis
- primary or secondary prophylaxis can be discontinued if CD4 count is >200 for >3 months
- pt not HIV but are on immunosuppressive meds or have underlying acquired or inherited immunodeficiency
tx options for pneumocystis prophylaxis
*bactrim ds one a day
*dapsone 100mg daily
*atovaquone 1500mg daily
combo of dapsone,pyrimethamine, leucovorin
pentamidine 300mg aerosol daily
Pneumocystis Jerovecii pneumonia-clinical features and diagnosis
*gradual onset of cough, fever, dyspnea
*CXR-bilateral intersitial infiltrates +/- pneumothorax
*Dx: sputum w direct staining
BAL, transbronchial biopsy
tx choice for pneumocystis Jerovecii pneumonia
TMP/SMX 15-20mg/kg oral or IV
CNS disease in AIDS:
- toxoplasmosis-mult ring enhancing lesions
- brain abscess-single or mult ring enhancing lesions
- CNS lymphoma-CD4<50, **Epstein Barr antibody + in 100%
- AIDS dementia-MRI=atrophy
- vasc.myelopathy-weakness, spastic, hyperreflexia
- multifocal leukoencephalopathy_JC virus
- radiculopathy, myopathy (HIV virus or AZT)
- peripheral neuropathy(HIV,HIV meds can cause)
cryptococcal meningitis
- most common cause of meningitis in HIV patients
- headache may be only symptom
Dx: India ink on spinal fluid in 75%, crypt antigen on blood,CSF
Tx:amphotericin B +/- flucytosine
serial spinal taps to decrease pressure if incr neuro signs
fluconazole prophylaxis after tx of acute infection
Histoplasmosis in HIV
- fever,hepatosplenomegaly, lung infiltr., splenic calcification
- dx: serum and urine H capsulatum antigen
- tx: amphotericin B for 7-14 days then itraconaole prophylaxis
diarrhea in AIDS
- bacterial: salmonella,shigella,campylobacter, M. avium
- viral: CMV, HSV, HIV
- drugs: DDI, protease inhibitors
* Protozoa: cryptosporidium, giardia, E. histolytica
CMV infection in AIDS
- features: retinitis, esophagitis, colitis
* Tx: ganciclovir or foscarnet IV, valganciclovir orally
Hepatitis C coinfection with HIV
- increased rate of progression to cirrhosis and HCC
- tx; 48 weeks regardless of genotype
- NO ribovirin if on AZT or DDI
Hepatitis B coinfection with HIV
- increased risk of chronic infection and cirrhosis
- long term tx
- if HIV needs tx, tx with 2 drugs that are also active against HBV (lavivudine, tenofovir, emtricitabine)
- if only need tx HBV, dont use above
clinical presentation of endocarditis
- fever, wt loss, myalgia, arthralgia, back pain , splenomegaly
- heart murmur, clubbing, petechiae, subungual hemorrhages
- Osler’s nodes
- roth spots
- janeway lesions
common organism with native valve endocarditis
- streptococcus, staph. aureus
- enterococcus
- HACEK: haemophilus, actinobacillus, cardiobacterium, eikenella, kingella
common organisms in IV drug users with endocarditis
- staph aureus
- streptococcus, enterococcus
- gram (-)
- fungus
common organisms with prosthetic valve endocarditis
- staph epidermidis, staph aureus
- gram (-)
- fungus
- streptococcus
empiric tx of endocarditis
vanco and gent, see specific valve type
indications for surgery in endocarditis
- persistent positive blood cultures
- moderate to severe CHF due to valve dysfunction
- recurrent emboli
- myocardial or valve ring abscess (heart block)
- large vegetation >10mm
- fungal or brucella endocarditis
- relapse of prosthetic valve endocarditis p optimal treatment
catheter related Intravascular infection prevention
- chlorhexidine for skin decontamination
- antibiotic coated catheter
- catheter care teams
- no need to routinely replace central catheters
diagnosis of catheter related intravascular infections
*isolate pathogen from peripheral blood culture AND either blood culture specimen from central line or culture of catheter tip
treatment of catheter related intravascular infections
- vanco + gent or 3rd gen cephalosporin
- remove catheter if: severe sepsis, suppurative thrombophlebitis, endocarditis, osteomyelitis, tunnel infection or infections due to: s. aureus, gram (-), fungus.
staph. aureus bacteremia
treat for 2 week if TEE (-), 4 weeks if +
empiric tx of bacterial meningitis with nondiagnostic gram stain
age 3 months to age 60:ceftriaxone + vancomycin
age > 60: ampicillin + ceftriaxone + vanco
- ceftriaxone or cefotaxime for both above
tx bacterial meningitis based on gram stain
- gram (+) cocci: vanco + ceftiaxone or cefotaxime
- gram (-) cocci: ceftriaxone or cefotaxime
- gram (+) bacilli: amp + gent
- gram (-) bacilli: ceftriaxone or cefotaxime or ceftazidime + gent
prophylaxis for meningococcal meningitis
- household contacts, day care contacts
- others with prolonged contact >8 hours in close proximity (3 feet) in the week before onset of patient symptoms
- any one exposed to patients oral secretions
- rifampin 600mg BID X 2days
- meningococcal vaccine to household contacts
predisposing conditions for brain abscess
- otitis media,mastoiditis, sinusitis
* pyogenic infections in chest or other body sites
brain abscess clinical features
headache, fever, focal neurological deficit
brain abscess dx & tx
Dx: MRI-ring enhancing lesion,stereotactic needle aspiration for gram stain and culture
Tx empiric: *head trauma or neurosurg-vanco + ceftiaxone, *hematogenous-vanco and flagyl, *oral focus-flagyl + PCN G, *ear or sinus-flagyl and ceftriaxone
clinical presentation of TB
- primary-infiltrates middle/lower lungs w ipsilateral hilar adenopathy
- reactivation- upper lobe infiltr, freq w cavitation
- extra pulm-l. nodes, pleura, bone,joints, GU, CNS
Dx of TB
- latent infection-tuberculin skin test
- interferon gamma release assay-no cross react w BCG-more specific than tuberculin skin test
*active TB-imaging, AFB smear & culture, histopath of bx sample, NAA-provide dx in 2 days,
Tx of TB
INH + Rifampin + PZA + ethambutol X 2 months then
INH + Rifampin X 4 more months
latent TB testing-PPD, positive if >/+ 5mm in:
*HIV +
recent contact with an active case
CXR consistent with old TB
immunosuppressed
PPD >/= 10mm positive in:
- IVDU,alcoholic, homeless, medically underserved (low income)
- immigrant(<5yrs) from high prevalence area
- has disease assoc with high risk of TB
- health care workers, resident/staff long term care facility
- recent conversion
diseases assoc with high risk of TB
*silicosis, diabetes, CRF, gastrectomy, malnutrition, leukemia, lymphoma, wt loss >10%, jejunoileal bypass, cancer of head or neck
indications for TB prophylaxis
*all pt with + ppd
*high risk exposure even if ppd negative:
recent close contact for at least 12 hours w infectious TB within 3 months esp if contact is young child or immunocompronised
*repeat ppd 3 mo after contact ended, if ppd-,stop tx, + cont tx
tx for TB prophylaxis, one of regimens below
*INH for 9 months
*rifampin x 4 months
*INH + rifampin X 3 months
*
PPD testing in nursing home
- test all admitted to NH,if negative, repeat in 1 week.
* if + (>/= 10mm) INH prophylaxis
Interpretation of ppd test in patient with prior BCG
interpret same way as someone without this exposure if BCG was given > 10 years ago
*interferon-gamma release assays (Quantiferon-TB gold) results are not affected by prior BCG
cystitis : s/s, tx
s/s:dysuris, urgency, freq, suprapubic pain, hematuria (no fever)
Tx: 3 day sulfa, 5 day nitrofurantoin, single dose fosfomycin
*pregnancy: 7 day augm nitrofurantoin, cephalosporin, 3gm single dose fosfomycin
Pyelonephritis
- fever,chills,flank pain
- do gm stain, C&S, U/S bladder,renal
- outpt:cipro/levoflox x 7 days
- inpt-see other-IV levaq,rocephin etc
asymptomatic bacteriuria
*tx only in pregnancy, neutropenia, renal transplant pt, urinary obstruction,and prior to invasive urological procedures
urinary catheter related infections
culture only if symptomatic
*keep urine collection bag below level of bladder best way to prevent urinary infections
acute prostatitis
*fever, chills, lbp or perineal pain, dysuria, freq.,urgency
*edematous tender prostate
bactrim is tx of choice, alt fluoroquinolone. tx 4-6 weeks
chronic prostatitis
- s/s recurrent UTI w isolation of same organism from urine
- prostate NOT tender of enlarged
- culture urine BEFORE & AFTER prostate massage, test for chlamydia
- TX: quinolone for at least 6 weeks, bactrim alternative
recurrent UTI (>3/year) in women
- related to coitus-postcoital prophylaxis
* not related to coitus- daily or 3x/wk tx with TMP or bactrim or nitrofurantoin or cipro etc
Lyme disease
- Borrelia bergdorferi
- spread tick Ixodes species
- must be attached >36 hrs to transmit disease
*stage 1: 3-30days p bite:fever, erythema migrans >5cm w central clearing
S.2:fever fatigue,arthralgia,mult annular lesions, neuro sympt
S.3:arthritis (#1knees),encephalopathy,spenomegaly, gen, adenopathy,acrodermatitis-red violaceous ->sclerotic/atrophic
Dx Lyme disease
*serology: ELISA+ then confirm by western blot
IGM western blot + if 2 of 3 bands +
IGG western blot + if 5 of 10 bands +
*after tx IG titers fall slow and may persist many years
- in prev tx patient, a +IGM titer is not indication to retreat unless typical features are present
- culture of skin lesion
- spirochete DNA by PCR on joint fluid or CSF
Post Lyme disease syndrome
- persistent fatigue, myalgias, arthralgias or cognitive difficulties
- no clinical benefit from further treatment
Tx Lyme disease-erythema migrans
first degree AV block
facial paralysis
arthritis
doxy 100mg BID or
amox 500mg TID or
cefuroxime 500mg BID
*tx 14-21 days all except tx arthritis for 28 days
tx Lyme disease-neurologic disease
high degree AV block with PR interval >.3s
persistant or recurrent arthritis
*IV ceftriaxone 2gm/day or cefotaxime 2gm every 8 hours for 14-28 days
prophylaxis after tick bite
- doxycycline 200mg single dose within 72 hr of tick removal
- indicated if tick attached >36 hours and is adult or nymphal tick (larvae ticks do not transmit disease)
- prophylaxis reduces risk of acquiring dz by 85%
Rocky Mountain spotted fever
- R. rickettsii
- incubation period 2-14 days
- s/s:fever,headache,myalgias, N/V, macular rash wrists/ankles by day 3-becomes petechial in few days
Dx: confirm immunohistologic exam of skin bx
serology (IFA) positive by 7-10 days
TX: doxy 100mg BID, po or IV, chloramphenicol in pregnancy
*complicaions:hypotension, noncardiac pulm. edema,meningoencephalitis
Ehrlichiosis (Human Granulocytic Anaplasmosis)
- fever,chills,vomiting,diarrhea, confusion,shock
- leukopenia, thrombocytopenia, incr AST/ALT
- peripheral smear: morulae in neutrophils, PCR, IFA
- tx:doxycycline, rifampin in pregnant
Babesiosis
- B. microti-NE coast US
- incubation :1-4 wk after bite, 1-9 wk after transfusion
- deer tick-ioxdes scapularis
- severe illness in immunocompromised
*protozoa invades RBCs and produce malaria like illness-fever, HA, myalgia,hepatosplenomegaly, retinal infarct, thrombocytopenia, hemolytic anemia-low haptoglobin
Dx:blood smear-pleomorphic ring forms, do PCR
tx-azitro and atovaquone tx of choice
osteomyelitis
- hematogenous-long bones, vertebrae-s.aureus, gram-ve
- contiguous infection-tibia,femur,skull, mandible-mixed organisms
- vasc. insufficiency-feet-mixed organisms
DX: best for early dx-MRI or three phase bone scan
plain xrays negative up to 2 weeks
diabetic foot ulcers-probe of ulcer touches bone suggests it
*clavicular osteo-after subclavian vein catheter
*sternoclavicular or sacroiliac bone osteo-think IV drug user
toxic shock syndrome assoc with these organisms
staph
strep
staphylococci toxic shock syndrome causes
- menstruating-tampons
* non-menstruating-wound infection, skin & soft tissue infections, infected implants
clinical features of toxic shock syndrome
- fever
- hypotension
- diffuse sunburn type rash
- diarrhea
tx of osteomyelitis
- remove offending items-tampons, catheters, packing,implant
- IV fluids
- IV vanco and clindamycin +/- immunoglobulin
complications of osteomyelitis
- ARDS
- DIC
- multi system organ failure
parvovirus B19 infection
- erythema infectiosum (slap cheek appearance)
- polyarthritis
- aplastic crisis in chronic hemolytic anemias
- red cell aplasia in HIV+
- hydrops fetalis or fetal death
Malaria
- 5 major species of parasite Plasmodium
- transmission-bite of female anopheles mosquito
- P. falciparum, P.vivax, P.ovale,P.malariae, I.knowlesi
Clinical features:
- headache,fatigue,myalgia followed by fever and chills
- hepatosplenomegaly,anemia,jaundice,thrombocytopenia
malarias that cause febrile paroxysms at regular intervals
- P. ovale
* P.vivax
severe falciparum malaria often see
- impaired consciousness, seizures
- severe hemolytic anemia
- ARDS,renal failure, pulmonary edema and shock
dx and tx of malaria
- thick and thin smears of blood
tx: chloroquine sensitive- chloroquine or amodiaquine - P. falciparum-artesunate +/-amodiaquine or atovaquone-proguanil or quinine + doxycycline
- primaquine x 14days-prevents relapse in P. vivax & ovale
anthrax
- bacillus anthracis-gram+ spore forming rod
* cutaneous or inhalation types
inhalation anthrax
- tx:cipro or doxycycline + clindamycin and/or rifampin X 60days
- s/s:fever,dyspnea,hypoxia,hypotension,hemorrhagic mediastinitis (symmetrical mediastinal widening), pleural effusion
cutaneous anthrax
- ulcer surrounded by non-pitting brawny edema
* tx:cipro po 7-10 days, 60 days if related to bioterrorism-alternte tx-doxy or amox if susceptible
post exposure to antrax prophylaxis
cipro or doxy po for 60 days + vaccine (amox can be used if sensitive)
anthrax vaccine
live attenuated vaccine
- 5 dose primary vaccine at day 0, week 4, 6mo,12mo,18mo
- booster -single dose at 1 year interval in persons who remain at risk
typical cellulitis, organism and treatment
gram + cocci
- IV cefaolin,nafcillin, ceftriaxone
- po dicloxacillin,cepphalexin…
tx cellulitis in diabetes and likely organisms
- gram + and - , anerobes
* amp/sulb, clinda & quinolone
organism and tx of buccal cellulitis
- H. influenzae
* ceftriaxone
organism and tx of dog or cat bite cellulitis
- P.multocida, anaerobes, capnocytophagia
- amox/clav
- moxifloxacin + clindamycin
organism and tx of human bite celllulitis
- strep, staph, anaerobes, Eikenella
- amox/clav
- pcn and cephalosporin